30687076|t|Metabolite Profile of Alzheimer's Disease in the Frontal Cortex as Analyzed by HRMAS 1H NMR.
30687076|a|Background: Investigation on neurochemical changes in the frontal cortex in individuals with Alzheimer's disease (AD) and different Apolipoprotein E (APOE) genotypes, using ex vivo solid-state high-resolution NMR analysis, may lead to a better understanding of the neurochemistry associated with AD as well as new AD-specific metabolite biomarkers that might potentially improve the clinical diagnosis of AD. Methods: Intact tissue samples of the frontal cortex were obtained from 11 patients and 11 age-matched non-demented controls. Metabolite profiles in all samples were analyzed ex vivo, using solid-state high-resolution magic angle spinning (HRMAS) 600 MHz 1H nuclear magnetic resonance (NMR). A logistic regression analysis was used to rank metabolites based on their level of contribution in differentiating the AD patient tissues and the controls, and different AD-associated APOE genotypes (APOE epsilon4 vs. APOE epsilon3). Results: Tissue samples from the AD patients showed significantly lower NAA/Cr (p = 0.011), Ace/Cr (p = 0.027), GABA/Cr (p = 0.005), Asp/Cr (p < 0.0001), mI/Cr (p < 0.0001), and Tau/Cr (p = 0.021), and higher PCho/Cr (p < 0.0001), GPCho/Cr (p < 0.0001), and alpha&beta-Glc/Cr (p < 0.0001) than the controls did. Specifically, a newly observed resonance at 3.71 ppm, referred to as alpha&beta-Glc, was observed in 90.9% of the AD samples (10/11). Samples with APOE epsilon4 also exhibited higher PCho/Cr (p = 0.0002), GPCho/Cr (p = 0.0001), alpha&beta-Glc/Cr (p < 0.0001), and lower Asp/Cr (p = 0.004) and GABA/Cr (p = 0.04) than the samples with APOE epsilon3 did. In the logistic regression analysis, PCho, GPCho, ASP, and alpha&beta-Glc were found to be the most relevant metabolites for differentiating the AD patient tissues and the controls, and different APOE genotypes. Conclusion: HRMAS 1H NMR with high spectral resolution and sensitivity offers a powerful tool to gain quantitative information on AD associated neurochemical changes. There are important neurochemical differences in the frontal cortex between the AD patient tissues and the controls, and between those with different APOE genotypes. The resonance (alpha&beta-Glc) found at 3.71 ppm in the AD patient tissues may be further investigated for its potential in the diagnosis and monitoring of AD.
30687076	22	41	Alzheimer's Disease	Disease	MESH:D000544
30687076	85	87	1H	Chemical	-
30687076	186	205	Alzheimer's disease	Disease	MESH:D000544
30687076	207	209	AD	Disease	MESH:D000544
30687076	225	241	Apolipoprotein E	Gene	348
30687076	243	247	APOE	Gene	348
30687076	389	391	AD	Disease	MESH:D000544
30687076	407	409	AD	Disease	MESH:D000544
30687076	498	500	AD	Disease	MESH:D000544
30687076	577	585	patients	Species	9606
30687076	757	759	1H	Chemical	-
30687076	914	916	AD	Disease	MESH:D000544
30687076	917	924	patient	Species	9606
30687076	965	967	AD	Disease	MESH:D000544
30687076	979	983	APOE	Gene	348
30687076	1013	1017	APOE	Gene	348
30687076	1062	1064	AD	Disease	MESH:D000544
30687076	1065	1073	patients	Species	9606
30687076	1101	1104	NAA	Chemical	-
30687076	1105	1107	Cr	Chemical	MESH:D002857
30687076	1121	1124	Ace	Chemical	MESH:C024789
30687076	1125	1127	Cr	Chemical	MESH:D002857
30687076	1141	1145	GABA	Chemical	MESH:D005680
30687076	1146	1148	Cr	Chemical	MESH:D002857
30687076	1162	1165	Asp	Gene	259266
30687076	1166	1168	Cr	Chemical	MESH:D002857
30687076	1186	1188	Cr	Chemical	MESH:D002857
30687076	1207	1210	Tau	Chemical	MESH:C000609666
30687076	1211	1213	Cr	Chemical	MESH:D002857
30687076	1243	1245	Cr	Chemical	MESH:D002857
30687076	1260	1265	GPCho	Chemical	MESH:D005997
30687076	1266	1268	Cr	Chemical	MESH:D002857
30687076	1287	1301	alpha&beta-Glc	Chemical	-
30687076	1302	1304	Cr	Chemical	MESH:D002857
30687076	1410	1424	alpha&beta-Glc	Chemical	-
30687076	1455	1457	AD	Disease	MESH:D000544
30687076	1524	1528	PCho	Chemical	MESH:C043572
30687076	1529	1531	Cr	Chemical	MESH:D002857
30687076	1546	1551	GPCho	Chemical	MESH:D005997
30687076	1552	1554	Cr	Chemical	MESH:D002857
30687076	1584	1586	Cr	Chemical	MESH:D002857
30687076	1611	1614	Asp	Gene	259266
30687076	1615	1617	Cr	Chemical	MESH:D002857
30687076	1634	1638	GABA	Chemical	MESH:D005680
30687076	1639	1641	Cr	Chemical	MESH:D002857
30687076	1675	1679	APOE	Gene	348
30687076	1744	1747	ASP	Gene	259266
30687076	1753	1767	alpha&beta-Glc	Chemical	-
30687076	1839	1841	AD	Disease	MESH:D000544
30687076	1842	1849	patient	Species	9606
30687076	1890	1894	APOE	Gene	348
30687076	1924	1926	1H	Chemical	-
30687076	2036	2038	AD	Disease	MESH:D000544
30687076	2153	2155	AD	Disease	MESH:D000544
30687076	2156	2163	patient	Species	9606
30687076	2223	2227	APOE	Gene	348
30687076	2254	2268	alpha&beta-Glc	Chemical	-
30687076	2295	2297	AD	Disease	MESH:D000544
30687076	2298	2305	patient	Species	9606
30687076	2395	2397	AD	Disease	MESH:D000544
30687076	Association	MESH:C024789	MESH:D000544
30687076	Negative_Correlation	MESH:D002857	MESH:D000544
30687076	Association	MESH:D005997	MESH:D000544
30687076	Negative_Correlation	MESH:C000609666	MESH:D000544
30687076	Association	MESH:D000544	348
30687076	Association	MESH:D005680	MESH:D000544
30687076	Association	MESH:D000544	259266
30687076	Association	MESH:C043572	MESH:D000544

